| Literature DB >> 29783897 |
Martina Vettoretti1, Giacomo Cappon1, Giada Acciaroli1, Andrea Facchinetti1, Giovanni Sparacino1.
Abstract
The recent announcement of the production of new low-cost continuous glucose monitoring (CGM) sensors, the approval of marketed CGM sensors for making treatment decisions, and new reimbursement criteria have the potential to revolutionize CGM use. After briefly summarizing current CGM applications, we discuss how, in our opinion, these changes are expected to extend CGM utilization beyond diabetes patients, for example, to subjects with prediabetes or even healthy individuals. We also elaborate on how the integration of CGM data with other relevant information, for example, health records and other medical device/wearable sensor data, will contribute to creating a digital data ecosystem that will improve our understanding of the etiology and complications of diabetes and will facilitate the development of data analytics for personalized diabetes management and prevention.Entities:
Keywords: continuous glucose monitoring; data integration; diabetes management; precision medicine; proactive medicine
Mesh:
Substances:
Year: 2018 PMID: 29783897 PMCID: PMC6134613 DOI: 10.1177/1932296818774078
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968